Search Orphan Drug Designations and Approvals
-
Generic Name: | 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6yl]-2-pyrimidinamine |
---|---|
Date Designated: | 02/10/2015 |
Orphan Designation: | Treatment of malignant mesothelioma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 03/08/2016 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Verastem, Inc. 117 Kendrick Street Suite 500 Needham, Massachusetts 02494 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-